SI3046537T1 - Farmacevtski pripravek ogljikovih hidratov za terapevtsko uporabo - Google Patents

Farmacevtski pripravek ogljikovih hidratov za terapevtsko uporabo

Info

Publication number
SI3046537T1
SI3046537T1 SI201431883T SI201431883T SI3046537T1 SI 3046537 T1 SI3046537 T1 SI 3046537T1 SI 201431883 T SI201431883 T SI 201431883T SI 201431883 T SI201431883 T SI 201431883T SI 3046537 T1 SI3046537 T1 SI 3046537T1
Authority
SI
Slovenia
Prior art keywords
carbohydrates
pharmaceutical preparation
therapeutic use
therapeutic
pharmaceutical
Prior art date
Application number
SI201431883T
Other languages
English (en)
Inventor
Agnes Rafalko
Tatyana Chernenko
Original Assignee
Glycomine, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glycomine, Inc. filed Critical Glycomine, Inc.
Publication of SI3046537T1 publication Critical patent/SI3046537T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
SI201431883T 2013-09-16 2014-09-16 Farmacevtski pripravek ogljikovih hidratov za terapevtsko uporabo SI3046537T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361878591P 2013-09-16 2013-09-16
EP14851464.9A EP3046537B1 (en) 2013-09-16 2014-09-16 Pharmaceutical preparation of carbohydrates for therapeutic use
PCT/US2014/055921 WO2015053910A2 (en) 2013-09-16 2014-09-16 Pharmaceutical preparation of carbohydrates for therapeutic use

Publications (1)

Publication Number Publication Date
SI3046537T1 true SI3046537T1 (sl) 2022-01-31

Family

ID=52813726

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201431883T SI3046537T1 (sl) 2013-09-16 2014-09-16 Farmacevtski pripravek ogljikovih hidratov za terapevtsko uporabo

Country Status (13)

Country Link
US (5) US20160228364A1 (sl)
EP (2) EP3046537B1 (sl)
CY (1) CY1125361T1 (sl)
DK (1) DK3046537T3 (sl)
ES (1) ES2892314T3 (sl)
HR (1) HRP20211564T1 (sl)
HU (1) HUE056624T2 (sl)
LT (1) LT3046537T (sl)
PL (1) PL3046537T3 (sl)
PT (1) PT3046537T (sl)
RS (1) RS62641B1 (sl)
SI (1) SI3046537T1 (sl)
WO (1) WO2015053910A2 (sl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA202192663A1 (ru) * 2019-03-29 2022-03-01 Глайкомайн, Инк. Липосомальные препараты и способы их применения и получения
US11058637B1 (en) * 2020-11-25 2021-07-13 King Abdulaziz University Surface-modified emulsomes for intranasal delivery of drugs
WO2023225102A1 (en) * 2022-05-18 2023-11-23 Glycomine, Inc. Continuous flow methods for producing mannose-1-phosphate, polymorphs of mannose-1-phosphate, and compositions and uses related thereto

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5013556A (en) * 1989-10-20 1991-05-07 Liposome Technology, Inc. Liposomes with enhanced circulation time
US7189705B2 (en) * 2000-04-20 2007-03-13 The University Of British Columbia Methods of enhancing SPLP-mediated transfection using endosomal membrane destabilizers
US7011845B2 (en) * 2000-05-09 2006-03-14 Mcp Hahnemann University β-glucans encapsulated in liposomes
WO2004103510A2 (en) * 2003-05-14 2004-12-02 The Regents Of The University Of Colorado Methods and apparatus using electrostatic atomization to form liquid vesicles
FR2897779B1 (fr) 2006-02-24 2009-04-17 Orphan Europ Sarl Manossyl-1 phosphates, procede de preparation et utilisation en therapeutique, notamment vis-a-vis dy syndrome cdg-la
JP2011518124A (ja) 2008-03-26 2011-06-23 ユニバーシティ・オブ・オックスフォード 小胞体ターゲッティングリポソーム
US20120135064A1 (en) * 2009-05-27 2012-05-31 Northeastern University Conjugated nanodelivery vehicles
SG181904A1 (en) 2009-12-23 2012-07-30 Novartis Ag Lipids, lipid compositions, and methods of using them
US20110257233A1 (en) 2010-03-19 2011-10-20 Sanford-Burnham Medical Research Institute Benzoisothiazolones as inhibitors of phosphomannose isomerase
WO2012018380A2 (en) * 2010-07-31 2012-02-09 The Scripps Research Institute Compositions and methods for inducing immune tolerance

Also Published As

Publication number Publication date
LT3046537T (lt) 2021-12-10
HRP20211564T1 (hr) 2022-01-21
US20200246266A1 (en) 2020-08-06
US11045419B2 (en) 2021-06-29
EP3046537B1 (en) 2021-07-14
EP3046537A4 (en) 2017-04-19
HUE056624T2 (hu) 2022-02-28
WO2015053910A2 (en) 2015-04-16
CY1125361T1 (el) 2023-03-24
US10449149B2 (en) 2019-10-22
PT3046537T (pt) 2021-10-07
US20160228364A1 (en) 2016-08-11
RS62641B1 (sr) 2021-12-31
US20220110871A1 (en) 2022-04-14
EP3046537A2 (en) 2016-07-27
DK3046537T3 (da) 2021-10-11
WO2015053910A3 (en) 2015-06-18
US20180036239A1 (en) 2018-02-08
US20240082155A1 (en) 2024-03-14
EP3954360A2 (en) 2022-02-16
EP3954360A3 (en) 2022-06-01
PL3046537T3 (pl) 2022-01-31
ES2892314T3 (es) 2022-02-03

Similar Documents

Publication Publication Date Title
IL287516A (en) Medicinal uses of empagliflozin
HRP20190101T1 (hr) Terapeutske uporabe empagliflozina
HK1213818A1 (zh) 依帕列淨的治療用途
LT2981271T (lt) Empagliflozino terapinis panaudojimas
PL3228313T3 (pl) Postacie dawkowania i zastosowania terapeutyczne L-4-chlorokineureniny
ZA201600027B (en) Pharmaceutical preparation
EP2968179A4 (en) RETARD-PRESENTATIONS
HUE056624T2 (hu) Szénhidrátok gyógyászati készítményei terápiás alkalmazásra
HK1204916A1 (en) Pharmaceutical application of anhydroicaritin
EP2984170A4 (en) USE OF ANTIBODY UREASE CONJUGATES FOR DIAGNOSTIC AND THERAPEUTIC PURPOSES
ZA201506465B (en) Pharmaceutical preparation
EP3052475A4 (en) Pharmaceutical use of 3-benzylsulfonylpropionitrile
GB201319595D0 (en) Combination of Analgesic drugs
GB201316468D0 (en) Combination of analgesic drugs
GB201318230D0 (en) Solutions for administration of pharmaceuticals